This country profile provides an overview of Zambia’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
93%
Blinding trachoma
61%
Intestinal worms
58%
Bilharzia
30%
River blindness
N/A
11.06 million people received treatment in Zambia in 2017 1.57 million people did not receive treatment in Zambia in 2017

Priorities for progress in Zambia

  • As a priority, Zambia should address the reasons for the gaps in treatment.
  • It should re-boot the preventive chemotherapy programme for endemic diseases, to achieve recommended WHO coverage targets.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage increased from 92% in 2016 to 93% in 2017.

People needing treatment
12.2m
People receiving treatment
11.37m

Blinding trachoma

Treatment coverage increased from 41% in 2016 to 61% in 2017.

People needing treatment
4.6m
People receiving treatment
2.81m

Intestinal worms

Treatment coverage increased from 57% in 2016 to 58% in 2017.

Pre-sch and school-aged children needing treatment
4.92m
Pre-school and school-aged children receiving treatment
2.85m

Bilharzia

Treatment coverage decreased from 32% in 2016 to 30% in 2017.

School-aged children needing treatment
3.12m
School-aged children receiving treatment
0.94m

River blindness

Zambia does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Zambia.